Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus

被引：0
|
作者：
Yanli Zeng
Qiaoduan Lin
Liang Yu
Xuelian Wang
Yiqiang Lin
Yan Zhang
Shuidi Yan
Xinxin Lu
Yijing Li
Weibin Li
Yun Xiao
机构：
[1] Xiamen University,Center of Clinical Laboratory, Zhongshan Hospital, School of Medicine
[2] Zhongshan Hospital of Xiamen University,Ultrasonography Department
[3] Zhongshan Hospital of Xiamen University,Department of Obstetrics and Gynecology
[4] The 900Th Hospital of Joint Logistic Support Force,Institute for Laboratory Medicine
来源：
BMC Immunology | / 22卷
关键词：
CXC ligand 1 (CXCL1); Growth-related oncogene-α (GRO-α); High-avidity IgG ANAs (HA IgG ANAs); Systemic lupus erythematosus (SLE); Lupus nephritis (LN);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus
    Urbonaviciute, V.
    Voll, R. E.
    JOURNAL OF INTERNAL MEDICINE, 2011, 270 (04) : 309 - 318
  • [42] Mean platelet volume may not be a marker for disease activity in children with systemic lupus erythematosus
    Beyan, Cengiz
    Beyan, Esin
    LUPUS, 2021, 30 (05) : 854 - 855
  • [43] Evaluation of Erythrocyte Sedimentation Rate As a Marker of Disease Activity in Patients with Systemic Lupus Erythematosus
    Han, Bobby Kwanghoon
    Rathwell, Elizabeth
    Ng, Bernard
    Wener, Mark
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus
    Manzi, S
    Ahearn, JM
    Salmon, J
    LUPUS, 2004, 13 (05) : 298 - 303
  • [45] Beta2-Microglobulin Can Be a Disease Activity Marker in Systemic Lupus Erythematosus
    Kim, Hyoun-Ah
    Jeon, Ja-Young
    Yoon, Jeong-Moon
    Suh, Chang-Hee
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (04): : 337 - 340
  • [46] Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus
    Suleiman, Suleiman
    Kamaliah, Daud
    Nadeem, Afzal
    Naing, Nyi Nyi
    Maraina, Che Hussin Che
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2009, 12 (02) : 100 - 106
  • [47] SERUM THROMBOMODULIN - A NOVEL MARKER OF DISEASE-ACTIVITY IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    BOEHME, MWJ
    NAWROTH, PP
    KLING, E
    LIN, J
    AMIRAL, J
    RIEDESEL, J
    RAETH, U
    SCHERBAUM, WA
    ARTHRITIS AND RHEUMATISM, 1994, 37 (04): : 572 - 577
  • [48] Patterns of disease activity in systemic lupus erythematosus
    Barr, SG
    Zonana-Nacach, A
    Magder, LS
    Petri, M
    ARTHRITIS AND RHEUMATISM, 1999, 42 (12): : 2682 - 2688
  • [49] INTERFERON-RELATED CHEMOKINE CXCL-10(IP-10) IN INCOMPLETE SYSTEMIC LUPUS ERYTHEMATOSUS; A POTENTIAL PREDICTIVE BIOMARKER FOR DISEASE PROGRESSION?
    Lambers, W.
    De Leeuw, K.
    Jonkman, M. F.
    Bootsma, H.
    Westra, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S43 - S43
  • [50] The role of the chemokine CXCL1 in epithelialization, inflammation and ageing
    Katsouli, M.
    Fimmel, S.
    Makrantonaki, E.
    Mueller, C.
    Zouboulis, C. C.
    EXPERIMENTAL DERMATOLOGY, 2011, 20 (02) : 166 - 167
12345